Related Experiment Video
Updated: Aug 18, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis
Claire Arnaud1, Niels R Veillard, François Mach
1Division of Cardiology, Foundation for Medical Research, 64, Avenue de la Roseraie, 1211 Geneva University Hospital, Switzerland.
Insights
Statins, used to treat high cholesterol, offer benefits beyond lowering lipids by impacting key cellular pathways. These cholesterol-independent effects may play a role in preventing atherosclerosis.
Area of Science:
- Cardiovascular Science
- Biochemistry
- Pharmacology
Background:
- Atherosclerosis and its complications are leading causes of death globally.
- Statins are primary treatments for dyslipidemia, significantly reducing cardiovascular events.
- The rapid efficacy of statins suggests effects beyond cholesterol reduction.
Purpose of the Study:
- To review the pleiotropic, or cholesterol-independent, effects of statins.
- To explore how these effects modulate the process of atherogenesis.
Main Methods:
- Literature review of studies on statin mechanisms and effects.
- Analysis of the biochemical pathways influenced by statins, including HMG-CoA reductase inhibition.
Main Results:
- Statins inhibit 3-hydroxyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase, impacting cholesterol synthesis.
- Mevalonate, a product of HMG-CoA reductase, is a precursor for isoprenoids like farnesyl pyrophosphate and geranylgeranyl pyrophosphate.
- Statins regulate small signaling proteins Ras and Rho by inhibiting their prenylation, leading to non-lipid-lowering effects.
Conclusions:
- Statins exhibit beneficial pleiotropic effects that could influence atherogenesis.
- These cholesterol-independent actions, mediated by the inhibition of prenylated proteins, contribute to cardiovascular protection.
Abstract:
Atherosclerosis and its complications still represent the major cause of death in developed countries. Statins have revolutionized the treatment of dyslipidemia and demonstrated their ability to reduce and prevent coronary morbidity and mortality. Statins inhibit 3-hydroxyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase, an enzyme crucial to cholesterol synthesis. The effectiveness and rapidity of statin-induced decreases in coronary events led to the speculation that statins possess cholesterol-independent effects. Since mevalonate produced by the HMG-CoA reductase is not only the precursor of cholesterol, but also of non steroidal isoprenoid compounds, such as the farnesyl pyrophosphate and the geranylgeranyl pyrophosphate, statins also regulate the small signaling proteins, Ras and Rho. Thus, inhibition of these prenylated proteins might account for the non-lipid lowering effects of statins. In this review, we describe the numerous beneficial pleiotropic effects of statins that could modulate atherogenesis.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Inflammation
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Atherosclerosis I: Introduction